Comparison
Why is GlaxoSmithKline Pakistan Ltd. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 15.50
2
The company has declared Positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at PKR 5,208.62 MM
- NET PROFIT(HY) Higher at PKR 5,081.31 MM
- ROCE(HY) Highest at 30.76%
3
With ROE of 26.6, it has a attractive valuation with a 4 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 0%, its profits have risen by 1136.1% ; the PEG ratio of the company is 0
How much should you hold?
- Overall Portfolio exposure to GlaxoSmithKline Pakistan Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is GlaxoSmithKline Pakistan Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
GlaxoSmithKline Pakistan Ltd.
-100.0%
4.17
49.36%
Pakistan KSE 100 Share
60.28%
2.81
22.77%
Quality key factors
Factor
Value
Sales Growth (5y)
10.70%
EBIT Growth (5y)
30.01%
EBIT to Interest (avg)
15.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
2.23
Tax Ratio
37.88%
Dividend Payout Ratio
48.72%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.87%
ROE (avg)
16.75%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
4.68
EV to EBIT
9.57
EV to EBITDA
8.78
EV to Capital Employed
5.73
EV to Sales
2.08
PEG Ratio
0.06
Dividend Yield
3.49%
ROCE (Latest)
59.85%
ROE (Latest)
30.99%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
18What is working for the Company
OPERATING CASH FLOW(Y)
Highest at PKR 5,208.62 MM
NET PROFIT(HY)
Higher at PKR 5,081.31 MM
ROCE(HY)
Highest at 30.76%
OPERATING PROFIT MARGIN(Q)
Highest at 26.08 %
RAW MATERIAL COST(Y)
Fallen by -145.23% (YoY
-10What is not working for the Company
INTEREST(Q)
At PKR 114.1 MM has Grown at 60.62%
Here's what is working for GlaxoSmithKline Pakistan Ltd.
Net Profit
At PKR 5,081.31 MM has Grown at 240.83%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (PKR MM)
Operating Cash Flow
Highest at PKR 5,208.62 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (PKR MM)
Operating Profit Margin
Highest at 26.08 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
Higher at PKR 5,081.31 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (PKR MM)
Raw Material Cost
Fallen by -145.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at PKR 319.44 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (PKR MM)
Here's what is not working for GlaxoSmithKline Pakistan Ltd.
Interest
At PKR 114.1 MM has Grown at 60.62%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (PKR MM)






